1. bookVolume 132 (2022): Edizione 1 (January 2022)
Dettagli della rivista
Prima pubblicazione
23 Apr 2014
Frequenza di pubblicazione
1 volta all'anno
access type Accesso libero

SARS-CoV-2 antibody screening in healthcare workers: lessons learned from the first months of COVID-19 outbreak in Europe. Significance of serology testing for effective pandemic management and reduction of the occupational risk

Pubblicato online: 20 Jul 2022
Volume & Edizione: Volume 132 (2022) - Edizione 1 (January 2022)
Pagine: 1 - 10
Dettagli della rivista
Prima pubblicazione
23 Apr 2014
Frequenza di pubblicazione
1 volta all'anno

Introduction. Detected in 2019 in Wuhan, China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing a coronavirus disease 2019 (COVID-19), has changed almost all aspects of human lives. It has had an enormous impact on societies, economies and politics across the world. Nevertheless, first and foremost, it has led to a global health crisis on an unprecedented scale. Since the pandemic’s beginning, one of the greatest global challenges has been to stop the spread of infection among healthcare workers (HCWs). As a front-line fighters, they are at higher risk of contracting SARS-CoV-2 than other professions.

Aim. The study aimed to determine the role of serological testing among HCWs by analyzing screening results for the presence of SARS-CoV-2 antibodies in this group in 12 European countries during the first wave of the pandemic.

Material and methods. Pubmed, MEDLINE, Web of Science, Google Scholar, and WHO COVID-19 databases were searched for studies on screening among HCWs using immunoassays or chemiluminescence assays for preventive purposes and determining the percentage of HCWs with acquired immunity to SARS-CoV-2. The number of 30 papers were selected. Immunoglobulin G (IgG) percentage was analyzed, and determination of immunoglobulin A (IgA) and immunoglobulin M (IgM) antibodies and their diagnostic usefulness.

Results. The screening results of HCWs were juxtaposed with epidemic situation of that time and public health measures in given country.

Conclusion. Introduction of routine serological testing of HCWs could be a valuable strategy to monitor the occupational risk in this group and effectiveness of local epidemic management strategies.


1. Cheng S-C, Chang Y-C, Fan Chiang Y-L, et al. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan. J Formos Med Assoc Taiwan Yi Zhi. 2020;119(3):747-51.10.1016/j.jfma.2020.02.007712725232113824 Search in Google Scholar

2. Lai C-C, Shih T-P, Ko W-C, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924.10.1016/j.ijantimicag.2020.105924712780032081636 Search in Google Scholar

3. WHO Director-General’s opening remarks at the media briefing on COVID-19 – 11 March 2020.. [https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-oncovid-19] (accessed: 1.06.2021) Search in Google Scholar

4. Download COVID-19 datasets. European Centre for Disease Prevention and Control. [https://www.ecdc.europa.eu/en/covid-19/data] (accessed: 1.06.2021) Search in Google Scholar

5. Rudberg A-S, Havervall S, Månberg A, et al. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020;11(1):5064.10.1038/s41467-020-18848-0754468933033249 Search in Google Scholar

6. He J, Guo Y, Mao R, Zhang J. Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis. J Med Virol. 2021;93(2):820-30.10.1002/jmv.26326740433432691881 Search in Google Scholar

7. Garcia-Basteiro AL, Moncunill G, Tortajada M, et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nat Commun. 2020;11(1):3500.10.1038/s41467-020-17318-x734386332641730 Search in Google Scholar

8. European Centre for Disease Prevention and Control. [https://www.ecdc.europa.eu/en] (accessed: 1.06.2021) Search in Google Scholar

9. Parikh R, Mathai A, Parikh S, Chandra Sekhar G, Thomas R. Understanding and using sensitivity, specificity and predictive values. Indian J Ophthalmol. 2008;56(1):45-50.10.4103/0301-4738.37595263606218158403 Search in Google Scholar

10. Guglielmi G. Fast coronavirus tests: what they can and can’t do. Nature. 2020;585(7826):496-8.10.1038/d41586-020-02661-232939084 Search in Google Scholar

11. Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients with Novel Coronavirus Disease 2019. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;71(16):2027-34.10.1093/cid/ciaa344718433732221519 Search in Google Scholar

12. Bułdak RJ, Woźniak-Grygiel E, Wąsik M, et al. SARS-CoV-2 Antibody screening in healthcare workers in non-infectious hospitals in two different regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective cohort study. Int J Environ Res Public Health. 2021;18(8):4376.10.3390/ijerph18084376807435733924173 Search in Google Scholar

13. Yu H-Q, Sun B-Q, Fang Z-F, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J. 2020;56(2):2001526.10.1183/13993003.01526-2020723682132398307 Search in Google Scholar

14. Huang Z, Chen H, Xue M, et al. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19. Clin Exp Immunol. 2020;202(2):210-9.10.1111/cei.13500740522832706417 Search in Google Scholar

15. Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;71(15):778-85.10.1093/cid/ciaa310718447232198501 Search in Google Scholar

16. Laboratory diagnostics SARS-CoV-2. [http://www.aotm.gov.pl/media/2021/04/Diagnostya-laboratoryjna-SARS-CoV-2-%E2%80%93-aktualizacja-Zalecen-wersja-2.0-7-kwietnia-2021-r.pdf] (accessed: 1.06.2021) Search in Google Scholar

17. Kavaliunas A, Ocaya P, Mumper J, et al. Swedish policy analysis for Covid-19. Health Policy Technol. 2020;9(4):598-612.10.1016/j.hlpt.2020.08.009745554932904437 Search in Google Scholar

18. Lidström A-K, Sund F, Albinsson B, et al. Work at inpatient care units is associated with an increased risk of SARS-CoV-2 infection; a cross-sectional study of 8679 healthcare workers in Sweden. Ups J Med Sci. 2020;125(4):305-10.10.1080/03009734.2020.1793039759472932684119 Search in Google Scholar

19. Rashid-Abdi M, Krifors A, Sälléber A, et al. Low rate of COVID-19 sero-conversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study. Infect Dis Lond Engl. 2021;53(3):169-75.10.1080/23744235.2020.184978733232190 Search in Google Scholar

20. He R, Zhang J, Mao Y, et al. Preparedness and responses faced during the COVID-19 pandemic in Belgium: An observational study and using the national open data. Int J Environ Res Public Health. 2020;17(21):7985.10.3390/ijerph17217985766309833143076 Search in Google Scholar

21. Silvia K. States of emergency in response to the coronavirus crisis: Situation in certain Member States; 2020. [https://www.europarl.europa.eu/RegData/etudes/STUD/2020/659385/EPRS_STU(2020)659385_EN.pdf] Search in Google Scholar

22. [https://www.gov.pl/web/belgia/informacja-w-zwiazku-z-rozprzestrzenianiem-sie-koronawirusa-w-belgii] (accessed 1.06.2021) Search in Google Scholar

23. Martin C, Montesinos I, Dauby N, et al. Dynamics of SARS-CoV-2 RTPCR positivity and seroprevalence among high-risk healthcare workers and hospital staff. J Hosp Infect. 2020;106(1):102-6.10.1016/j.jhin.2020.06.028731646832593608 Search in Google Scholar

24. Spain against COVID-19. [http://pism.pl/publikacje/Hiszpania_wobec_pandemii_COVID19] (accessed 1.06.2021) Search in Google Scholar

25. Gras-Valentí P, Chico-Sánchez P, Algado-Sellés N, et al. Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department. Enferm Infecc Microbiol Clin. 2021;39(7):319-25.10.1016/j.eimc.2020.09.015755677634629599 Search in Google Scholar

26. Moncunill G, Mayor A, Santano R, et al. SARS-CoV-2 seroprevalence and antibody kinetics among health care workers in a Spanish Hospital after 3 months of follow-up. J Infect Dis. 2021;223(1):62-71.10.1093/infdis/jiaa696771734133175145 Search in Google Scholar

27. Plümper T, Neumayer E. Lockdown policies and the dynamics of the first wave of the Sars-CoV-2 pandemic in Europe. J Eur Public Policy. 2020;0(0):1-21. Search in Google Scholar

28. Shields A, Faustini SE, Perez-Toledo M, et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020;75(12):1089-94.10.1136/thoraxjnl-2020-215414746204532917840 Search in Google Scholar

29. Shields AM, Faustini SE, Perez-Toledo M, et al. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response. MedRxiv Prepr Serv Health Sci. 2020. doi:10.1101/2020.11.12.20230763768534233236029 Apri DOISearch in Google Scholar

30. Razvi S, Oliver R, Moore J, Beeby A. Exposure of hospital healthcare workers to the novel coronavirus (SARS-CoV-2). Clin Med Lond Engl. 2020;20(6):e238-e40.10.7861/clinmed.2020-0566768734032962975 Search in Google Scholar

31. Martin CA, Patel P, Goss C, et al. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff. J Public Health. 2020:1-12.10.1093/pubmed/fdaa199771731733200200 Search in Google Scholar

32. Bampoe S, Lucas DN, Neall G, et al. A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health professionals. Anaesthesia. 2020;75(12):1614-9.10.1111/anae.1522932777861 Search in Google Scholar

33. Poulikakos D, Sinha S, Kalra PA. SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England. J Clin Virol. 2020;129:104545.10.1016/j.jcv.2020.104545733885632659709 Search in Google Scholar

34. Di Lorenzo G, Di Trolio R. Coronavirus Disease (COVID-19) in Italy: Analysis of risk factors and proposed remedial measures. Front Med. 2020;7. doi:10.3389/fmed.2020.00140716134332328496 Apri DOISearch in Google Scholar

35. Colombo AD, Impicciatore R. Analisi di 1.084 comuni italiani. In: Analisi dell’Istituto Cattaneo. Bologna: Fondazione di Ricerca istituto Carlo Cattaneo;2020. Search in Google Scholar

36. Conticini E, Frediani B, Caro D. Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy? Environ Pollut. 2020;261:114465. Search in Google Scholar

37. Murgante B, Borruso G, Balletto G, Castiglia P, Dettori M. Why Italy first? Health, geographical and planning aspects of the COVID-19 outbreak. Sustainability. 2020;12(12):5064.10.3390/su12125064 Search in Google Scholar

38. Lahner E, Dilaghi E, Prestigiacomo C, et al. Prevalence of Sars-Cov-2 infection in Health Workers (HWs) and diagnostic test performance: The experience of a Teaching Hospital in Central Italy. Int J Environ Res Public Health. 2020;17(12):4417.10.3390/ijerph17124417734535832575505 Search in Google Scholar

39. Plebani M, Padoan A, Fedeli U, et al. SARS-CoV-2 serosurvey in health care workers of the Veneto Region. Clin Chem Lab Med. 2020;58(12):2107-11.10.1515/cclm-2020-123632845861 Search in Google Scholar

40. Calcagno A, Ghisetti V, Emanuele T, et al. Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy. Emerg Infect Dis. 2021;27(1):303-5.10.3201/eid2701.203027777455633021927 Search in Google Scholar

41. Swiss Economy – Facts and Figures. [https://www.eda.admin.ch/about-switzerland/en/home/wirtschaft/uebersicht/wirtschaft---fakten-und-zahlen.html] (accessed: 1.06.2021) Search in Google Scholar

42. Giachino M, Valera CBG, Rodriguez Velásquez S, et al. Understanding the dynamics of the COVID-19 pandemic: A real-time analysis of Switzerland’s first wave. Int J Environ Res Public Health. 2020;17(23):8825.10.3390/ijerph17238825772988733261039 Search in Google Scholar

43. Kohler PP, Kahlert CR, Sumer J, et al. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study. Infect Control Hosp Epidemiol. 2021;42(5):604-8.10.1017/ice.2020.1244758201833028454 Search in Google Scholar

44. France and COVID-19: Economic Priorities and the Risk of Recession. [http://pism.pl/publikacje/COVID19_we_Francji_priorytety_gospodarcze_wobec_widma_recesji] (accessed: 30.06.2021). Search in Google Scholar

45. COVID-19 in France - democracy in isolation.[http://pism.pl/publikacje/COVID19_we_Francji_demokracja_w_izolacji] (accessed: 30.06.2021). Search in Google Scholar

46. Delmas C, Plu-Bureau G, Canouï E, et al. Clinical characteristics and persistence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in 4,607 French healthcare workers: Comparison with European countries. Infect Control Hosp Epidemiol. 2020:42(11):1406-8.10.1017/ice.2020.1309768417933143811 Search in Google Scholar

47. Finkenzeller T, Faltlhauser A, Dietl K-H, et al. SARS-CoV-2 antibodies in ICU and clinic staff : From Germany’s region with the highest infection rate. Med Klin Intensivmed Notfallmedizin. 2020;115(Suppl 3):139-45.10.1007/s00063-020-00761-5771390533274410 Search in Google Scholar

48. Péré H, Wack M, Védie B, et al. Sequential SARS-CoV-2 IgG assays as confirmatory strategy to confirm equivocal results: Hospital-wide antibody screening in 3,569 staff health care workers in Paris. J Clin Virol. 2020;132:104617.10.1016/j.jcv.2020.104617747073432927358 Search in Google Scholar

49. Mesnil M, Joubel K, Yavchitz A, et al. Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study). Anaesth Crit Care Pain Med. 2020;39(5):595-6.10.1016/j.accpm.2020.08.003745100032861816 Search in Google Scholar

50. Naumann E, Möhring K, Reifenscheid M, et al. COVID-19 policies in Germany and their social, political, and psychological consequences. Eur Policy Anal. 2020;6(2):191-202.10.1002/epa2.1091753729634616900 Search in Google Scholar

51. Korth J, Wilde B, Dolff S, et al. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2020;128:104437.10.1016/j.jcv.2020.104437721942532434708 Search in Google Scholar

52. Schmidt SB, Grüter L, Boltzmann M, Rollnik JD. Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff. PLoS ONE. 2020;15(6). doi:10.1371/journal.pone.0235417731628032584894 Apri DOISearch in Google Scholar

53. Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Science Translational Medicine. [https://stm.sciencemag.org/content/12/573/eabe2555] (accessed: 1.06.2021) Search in Google Scholar

54. Amann J, Sleigh J, Vayena E. Digital contact-tracing during the Covid-19 pandemic: An analysis of newspaper coverage in Germany, Austria, and Switzerland. PLOS ONE. 2021;16(2):e0246524.10.1371/journal.pone.0246524785755333534839 Search in Google Scholar

55. Desson Z, Lambertz L, Peters JW, et al. Europe’s Covid-19 outliers: German, Austrian and Swiss policy responses during the early stages of the 2020 pandemic. Health Policy Technol. 2020;9(4):405-18.10.1016/j.hlpt.2020.09.003783426933520639 Search in Google Scholar

56. Pilz S, Chakeri A, Ioannidis JP, et al. SARS-CoV-2 re-infection risk in Austria. Eur J Clin Invest. 2021;51(4):e13520.10.1111/eci.13520798858233583018 Search in Google Scholar

57. Orth-Höller D, Eigentler A, Weseslindtner L, Möst J. Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARSCoV-2 infection. Emerg Microbes Infect. 2020;9(1):1692-4.10.1080/22221751.2020.1793690747311132654611 Search in Google Scholar

58. Hackner K, Errhalt P, Willheim M, et al. Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence population. GMS Hyg Infect Control. 2020;15. doi:10.3205/dgkh000363765697633214993 Apri DOISearch in Google Scholar

59. Conyon MJ, He L, Thomsen S. Lockdowns and COVID-19 deaths in Scandinavia. Social Sci Res Network. 2020. doi:10.2139/ssrn.3616969 Apri DOISearch in Google Scholar

60. Trieu M-C, Bansal A, Madsen A, et al. SARS-CoV-2 – Specific neutralizing antibody responses in Norwegian health care workers after the first wave of COVID-19 pandemic: A prospective cohort study. J Infect Dis. 2021;223(4):589-99.10.1093/infdis/jiaa737779894333247924 Search in Google Scholar

61. Basso T, Nordbø SA, Sundqvist E, et al. Transmission of infection from non-isolated patients with COVID-19 to healthcare workers. J Hosp Infect. 2020;106(4):639-42.10.1016/j.jhin.2020.08.015743900932828865 Search in Google Scholar

62. Gujski M, Raciborski F, Jankowski M, et al. Epidemiological Analysis of the first 1389 cases of COVID-19 in Poland: A Preliminary report. Med Sci Monit Int Med J Exp Clin Res. 2020;26:e924702.10.12659/MSM.924702723300832379726 Search in Google Scholar

63. Introducing an epidemic in Poland. Coronavirus: Information and Recommendations. [http://www.gov.pl/web/koronawirus/wprowadzamy-stan-epidemii-w-polsce] (accessed: 1.06.2021). Search in Google Scholar

64. The Impact of the COVID-19 Pandemic on Greek Policy. [https://pism.pl/publications/The_Impact_of_the_COVID19_Pandemic_on_Greek_Policy] (accessed: 1.06.2021). Search in Google Scholar

65. Moris D, Schizas D. Lockdown during COVID-19: The Greek success. In Vivo. 2020;34(3 suppl):1695-9.10.21873/invivo.11963837802932503831 Search in Google Scholar

66. Vlachoyiannopoulos P, Alexopoulos H, Apostolidi I, et al. Anti-SARSCoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece. Clin Immunol Orlando Fla. 2020;221:108619.10.1016/j.clim.2020.108619759081033127563 Search in Google Scholar

67. Galanis P, Kaitelidou D, Prezerakos P, et al. Low seropositivity for SARSCoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greece. Public Health. 2021;198:223-9.10.1016/j.puhe.2021.07.029832440434482100 Search in Google Scholar

68. Goverment website: When to get vaccinated before traveling?Ministry of Health. Web Gov.pl. [http://www.gov.pl/web/zdrowie/kiedy-nalezy-zaszczepic-sie-przed-podroza] (accessed 1.06.2021). Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo